-
Entire Site
Products
Part Numbers
Applications
Technical Documents
Entire Site
Products
Part Numbers
Applications
Technical Documents
Publish Date | Press Release |
---|---|
02/07/2023 | Phenomenex – Today’s Biopharma Focus for Tomorrow’s Better World |
Publish Date | Press Release |
---|---|
08/23/2021 | Phenomenex Introduces New Biozen dSEC LC Columns |
06/17/2021 | Phenomenex Introduces NEW SINGLE GC Solution for Dioxin Analysis |
04/05/2021 | Phenomenex Announces Direct Sales and Support within Indonesia |
03/08/2021 | Phenomenex Expands Novum Product Line with Novum PRO SLE |
02/22/2021 | NEW bioZen Nano LC Columns |
Torrance, CA (March 21, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces a new 5 µm particle size to its family of Kinetex F5 pentafluorophenyl propyl (PFP) core-shell columns, extending the versatility of F5 to preparative LC and purification work. Kinetex F5 is a robust PFP core-shell phase that overcomes reproducibility and performance limitations of other PFP and F5 products on the market and significantly reduces method development time with its dynamic and responsive chemical functionality. With five retention mechanisms and five separation modes, Kinetex F5 is an effective orthogonal alternative to the widely used C18 and C8 phases. Kinetex F5 is an ideal solution for HPLC/UHPLC development work with its combination of polar and non-polar interactions, including hydrogen bonding, electrostatic, hydrophobic, aromatic and steric/planar mechanisms. The versatility of this phase gives scientists the ability to use reversed phase, 2D-LC, HILIC, SFC or even 100 percent aqueous separation modes.
Now available in three particle sizes – 1.7, 2.6, and the new 5 µm – Kinetex F5 is fully scalable from UHPLC to HPLC to preparative chromatography, making method transfer seamless between different lab or site instrumentation. The new F5 5 µm media is also available in high-performance Axia™-packed preparative columns from 21.1 mm to 50 mm ID.
Kinetex F5 delivers all the advantages of Phenomenex’ Core-Shell Technology including better resolution, higher efficiency, easy method transferability and cost savings from reduced solvent consumption. The new 5µm particle delivers performance that is comparable to or better than 3 µm conventional fully porous media, at lower backpressures. Users who upgrade existing 5 µm methods to Kinetex 5µm F5 can achieve greater performance at the same backpressure.
"Our F5 media is an excellent orthogonal tool for many applications," explains Simon Lomas, strategic marketing manager for Phenomenex. "The ability to scale and easily transfer methods from UHPLC to HPLC to preparative LC enables users to apply the versatility of this media across the board."
For more information regarding this article please contact:
Phenomenex Press Room Tel: 310-212-0555
Email: pressroom@phenomenex.com
Publish Date | Publication | Article Title |
---|---|---|
12/13/2019 | Cannabis testing: The need for robust methods and true transparency | |
05/08/2019 | Rapid Extraction and Analysis of PPCPs From Sediments |
Publish Date | Publication | Article Title |
---|---|---|
11/14/2018 | Chromatographic Analysis for PAT | |
11/12/2018 | High-Flow Weak Cation Exchange for Charge Variant Analysis | |
06/01/2018 | Bio-Inert versus Bio-Compatible: The Benefits of Different Column Materials in Liquid Chromatography... | |
02/23/2018 | Meeting the Demands of the Food Safety Laboratory Using Versatile Columns |
Publish Date | Publication | Article Title |
---|---|---|
07/18/2017 | SelectScience Interview: Improving Food Safety at the United States Department of Agriculture | |
06/20/2017 | Addressing the Challenges of Drug-to-Antibody Measurement | |
02/24/2017 | Dietary Supplements Method Modernization- A Review of Current Efforts to Modetnize Compendial Method... | |
02/14/2017 | How to Optimize Your Reversed Phase Chromatography |
Publish Date | Publication | Article Title |
---|---|---|
12/14/2016 | Customized Separation Solutions from PhenoLogix Experts | |
11/02/2016 | The Secrets Behind the Success of Phenomenex- Tips to the Top | |
10/06/2016 | The Phenomenex Story Part II: Leading the Field in Urine Analysis | |
09/27/2016 | Urinary Drug Testing: Small Changes for Big Improvements in Sensitivity | |
09/22/2016 | The Phenomenex Story Part I: The Architect Who Build a Chemistry Empire | |
07/6/2016 | Urine Analytics: The Good, The Bad, and The Ugly | |
07/20/2016 | Approaches to prescription opioid abuse testing |
Publish Date | Publication | Article Title |
---|---|---|
12/10/2015 | Allowable Adjustments to Pharmacopoeia Methods for Isocratic and Gradient Separations | |
10/1/2015 | New Approaches to Screening for Drug Abuse | |
04/09/2015 | Torrance Tribune - Crushing Malaria | |
03/03/2015 | Identifying the Increased Scope of Core-Shell Technology for HPLC and UHPLC Chromatographers |
Publish Date | Publication | Article Title |
---|---|---|
12/02/2014 | Eliminating Volumetric Haematocrit Bias Associated with DBS Sub-Punch Workflows Using a Novel Micros... |